All Press Releases
2016, 06, 22 — Press release / PILA PHARMA successfully completes new shares emission and strengthens the Board of Directors
Malmö, Sweden, 22 June 2016 PILA PHARMA successfully completes new shares emission and strengthensthe Board of Directors PILA PHARMA raises new capital to initiate the clinical assessment of XEN-D0501 as novel anti-diabetic agent PILA PHARMA AB, Malmö, Sweden announced today it has completed a successful new shares emission which will allow the company to progress its newly acquired clinical development candidate,…
PILA PHARMA CEO explains potential of “chili receptor” as diabetes therapy
Dr. Dorte Gram, CEO of PILA PHARMA AB, one of Sweden’s youngest biotech companies, talks to Mike Ward, global director of content for Informa Pharma Intelligence’s insights portfolio, about PILA’s history, its novel diabetes technology and why we should keep an eye on its lead asset that will be taking off with clinical studies in the near future. PILA owns…
2016, 03, 30 — Press release / PILA PHARMA Acquires Ario Pharma’s TRPV1Assets
The clinical assessment of a novel diabetes treatment seems within reach for PILA PHARMA with the acquisition of XEN-D0501, a clinical ready and safe TRPV1 antagonist development candidate